Atlas FDA

PERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY

FDA premarket approval P900066/S006 · decided 2002-12-10

Approval details

PMA number
P900066
Supplement
S006
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
PERFLUOROPROPANE FOR PNEUMATIC RETINOPEXY
Generic name
Gases used within eye to place pressure on detached retina
Applicant
Airgas Therapeutics, LLC
Date received
2002-08-13
Decision date
2002-12-10
Days to decision
119 days
Decision code
APPR
Product code
LPO
Advisory committee
Ophthalmic
Expedited review
No
Location
Plumsteadville, PA
Statement
APPROVAL TO ADD A MOLECULAR SIEVE SCRUBBING STEP AT THE END OF THE GAS MANUFACTURING PROCESS.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
ULSPIRA TS™ Nitric Oxide Therapy System (K242374)Airgas Therapeutics, LLC2025-01-17